版本:
中国

BRIEF-Horizon Pharma announces Health Canada approval of Procysbi 

June 19 Horizon Pharma Plc

* Horizon Pharma Plc announces Health Canada approval of Procysbi™ (cysteamine delayed-release capsules) for the treatment of nephropathic cystinosis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐